Genome-wide in vivo CRISPR screen identifies TGFβ3 as actionable biomarker of palbociclib resistance in triple negative breast cancerMOLECULAR CANCERIF33.92024-06-030OAAI
Combined in vitro/in vivo genome-wide CRISPR screens in triple negative breast cancer identify cancer stemness regulators in paclitaxel resistanceONCOGENESISIF6.42023-11-068OAAI
Comparative proximity biotinylation implicates the small GTPase RAB18 in sterol mobilization and biosynthesisJOURNAL OF BIOLOGICAL CHEMISTRYIF3.92023-11-013OAAI
In vivo genome-wide CRISPR screen in pancreatic ductal adenocarcinoma defines HSPE1 as a potential oncogene by acting through G2/M cell cycle arrestCANCER RESEARCHIF16.62023-04-040PRE
In vivo genome-wide CRISPR screen reveals breast cancer vulnerabilities and synergistic mTOR/Hippo targeted combination therapyNATURE COMMUNICATIONSIF15.72021-05-2481OAAI
Differential Regulation of Cancer Progression by CDK4/6 Plays a Central Role in DNA Replication and Repair PathwaysCANCER RESEARCHIF16.62021-03-0130OA
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向